Company intelligence / Profile preview

DEMEDICA

Oberursel, Hesse, Germany

Ownership: Private
Development stage: Other

Overview

Demedica is a German pharmaceutical company specializing in the development and distribution of niche medicinal products, with a primary focus on psychiatry and neurology. The company is a subsidiary of the Aristo Pharma Group, which allows it to leverage extensive manufacturing and distribution capabilities across Europe. Demedica is best known for its portfolio of central nervous system (CNS) medications, including the neuroleptic Melperon, used to treat restlessness, confusion, and sleep disorders. The company's business model centers on providing established therapeutic solutions and maintaining a reliable supply of essential psychiatric medications.

Therapeutic areas: PsychiatryNeurology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on DEMEDICA.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DEMEDICA.

Explore the full profile